Molecular diagnostics company is awarded $250,000 to continue development of cancer detection technologiesContinue reading
Molecular diagnostics company is awarded $250,000 to continue development of cancer detection technologiesContinue reading
Presentation at the Society for Toxicologic Pathology demonstrates the ability to quantify fibrosis in nonalcoholic steatohepatitisContinue reading
Achieve Your Business Goals and Drive Industry Conversation at AdvaMed 2013: The MedTech Conference Continue reading
Combining the resources and expertise of seven institutions in North America and Europe, the research program will offer insights into the molecular workings of heart muscle cells and how genetic mutations affect their function.Continue reading
A guest post by Representative Heather Carter, Chair of the Health and Human Services Committee, Arizona House of Representatives.Continue reading
MSDx, Inc. Awarded a Rapid Response Innovation Grant from The Michael J. Fox Foundation For the Development of Biomarkers in Parkinson’s DiseaseContinue reading
Washington, D.C. (June 13, 2013)
Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today issued the following statement on the U.S. Supreme Court’s decision regarding Myriad Genetics’ patent claims on isolated DNA molecules: Continue reading
BioPharm Insight Profiles MSDxContinue reading
RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response.Continue reading
Only Targeted Improvements NeededContinue reading